GlobeNewswire 8/15/2019 Silence Therapeutics Notice of results and R&D day
GlobeNewswire 7/18/2019 SILENCE THERAPEUTICS AND MALLINCKRODT ANNOUNCE COLLABORATION TO DEVELOP AND COMMERCIALIZE RNAi THERA...
GlobeNewswire 7/17/2019 RNA Therapy Markets to 2025: Insights Into Kidney Diseases, Cardiovascular, Infectious Diseases, Onc...
GlobeNewswire 3/7/2019 Global $1.81 Bn Antisense & RNAi Therapeutics Market 2017-2019 & 2025 - On-Going Developments in Bio...
GlobeNewswire 2/21/2019 Aduro Announces Changes to its Board of Directors
GlobeNewswire 1/15/2019 SLN124 granted Orphan Drug Designation by EMA for the treatment of β-Thalassemia
GlobeNewswire 1/9/2019 Global Hereditary Hematological Disorders Drug Development Pipeline Review 2018
GlobeNewswire 12/19/2018 Silence Therapeutics advances next RNAi medicine
GlobeNewswire 9/26/2018 Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
GlobeNewswire 8/7/2018 Silence Therapeutics litigation: patisiran EU marketing authorisation imminent
GlobeNewswire 7/11/2018 Pulmonary Arterial Hypertension (PAH) Therapeutics 2015-2022 - Global Strategic Business Report 2018
GlobeNewswire 2/21/2018 Gene Therapies Market Report 2018: Current Status of the Field and the Relative Clinical and Commerc...
GlobeNewswire 11/15/2017 Two Report Package: Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics
GlobeNewswire 8/10/2017 Global mRNA Vaccines & Therapeutics Markets 2017: Industry Analysis of Technologies, Pipelines, Stak...
GlobeNewswire 5/8/2014 Swedish Orphan Biovitrum AB (publ): Annette Clancy joins Sobi's Board of Directors
GlobeNewswire 4/3/2014 Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
GlobeNewswire 5/21/2010 Clavis Pharma appoints two internationally experienced pharma executives